HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Two cases of anti-epiligrin cicatricial pemphigoid with and without associated malignancy.

Abstract
Anti-epiligrin cicatricial pemphigoid (AECP) is a chronic, mucous membrane-dominated, subepithelial blistering disease characterized by circulating anti-basement membrane zone auto-antibodies to laminin 5. Recent studies have shown that people with AECP have an increased relative risk for malignant tumours. In this report we describe two patients with AECP. In both cases, indirect immunofluorescence demonstrated circulating IgG anti-basement membrane auto-antibodies that bound to the dermal side of 1M NaCl split normal skin. Immunoblotting using laminin 5 purified from keratinocyte extract as a substrate showed that the IgG antibodies of patient 1 reacted with the 140-kDa beta3 subunit of laminin 5 and IgG antibodies of patient 2 reacted with the 165-kDa and 145-kDa alpha3 subunits. Patient 1 had prostate carcinoma and his blistering was resistant to therapy. Patient 2 had no detectable malignancy and treatment with doxycycline was successful.
AuthorsSatoshi Fukushima, Kiyofumi Egawa, Hazuki Nishi, Shoji Wakasugi, Norito Ishii, Takashi Hashimoto, Kim B Yancey, Hironobu Ihn
JournalActa dermato-venereologica (Acta Derm Venereol) Vol. 88 Issue 5 Pg. 484-7 ( 2008) ISSN: 0001-5555 [Print] Sweden
PMID18779887 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Infective Agents
  • Autoantibodies
  • Cell Adhesion Molecules
  • Immunoglobulin G
  • kalinin
  • Dapsone
  • Doxycycline
Topics
  • Adenocarcinoma (complications)
  • Aged
  • Aged, 80 and over
  • Anti-Infective Agents (therapeutic use)
  • Autoantibodies (blood)
  • Cell Adhesion Molecules (immunology)
  • Dapsone (therapeutic use)
  • Doxycycline (therapeutic use)
  • Drug Resistance
  • Female
  • Fluorescent Antibody Technique, Indirect
  • Humans
  • Immunoglobulin G (blood)
  • Male
  • Pemphigoid, Benign Mucous Membrane (diagnosis, drug therapy, immunology)
  • Prostatic Neoplasms (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: